PTC Therapeutics | PTCT - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -0.03 -0.43 10.04 May/07
FY2025Q4 Dec/2025 -1.67 -0.47 -0.85 Feb/19
FY2025Q3 Sep/2025 0.20 -1.02 -1.39 Nov/04
FY2025Q2 Jun/2025 -0.83 -1.07 -1.29 Aug/07
FY2025Q1 Mar/2025 10.04 -1.35 -1.20 May/06




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Cytokinetics USD -1.67 0.17 2026-03
Daiichi Sankyo JPY 48.75 1.96 2026-03
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 2.03 0.17 2026-03
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Ironwood Pharmaceuticals USD 0.24 0.25 2026-03
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Novartis USD 1.99 0.04 2026-03
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sarepta Therapeutics USD 3.16 6.74 2026-03
TG Therapeutics USD 0.12 0.02 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03
Xencor USD -1.71 1.62 2026-03